Skip to main content

Formulation Techniques We Use

Ophthalmic and injectable formulations built with the right technique for the molecule—optimized for target concentration, sterile filterability, particle size, and clean tech transfer.

Let's Talk

Why the Choice of Formulation Technique Matters as Much as Excipients

Excipients set the what; the formulation technique determines the how—how it runs in manufacturing, holds up on stability, and performs in the clinic.

  • Manufacturing: techniques fine tune particle/ droplet size, viscosity, scalability and filterability.
  • Stability: incomplete removal of water or solvents, aggregation, and Oswald ripening are all a result of technique
  • Clinical performance: particle/droplet size and viscosity directly impact administration tolerability and pharmacokinetics (e.g., release rate).  

Techniques We Use

Technique selected for outcomes, not novelty—simple when possible, advanced when necessary.

Microfluidics

Applicable to highly crystalline APIs that need precise size control (e.g., polymeric micelles and liposomal).

Best for: tight PDI, tunable particle size.
We watch: shear and temperature, scalability, and particle properties

High-Shear Mixing / Homogenization

Simple and cost-effective high-energy mixing for uniform distribution of emulsions and nanoparticle systems.

Best for: emulsions, pre-mix for nanoparticle formulations, in particular polymeric and liposomal.
We watch: temperature, aeration, and shear-induced degradation.

Lyophilization-Enabled Nanoparticle Self-Assembly

Solvent-based lyophilization to generate self-assembling micelle & polymeric nanoparticle formulations upon reconstitution; useful for hydrophobic APIs, and drugs with shelf-stability challenges.

 

Best for: high loading with optical clarity, improved stability/shipping.
We watch: residual water & solvents, cake morphology, reconstitution time, and particle properties.

Emulsification

Uniform droplet formation via specialized mixing (including high-shear). Even dispersion for hydrophobic drugs; enables higher concentrations and improved pharmacokinetics. 

Best for: ophthalmic (sub-micron) and injectable formulations within viscosity limitations.
We watch: uniformity, sterile filterability, and storage stability (e.g., Ostwald ripening). 

Nanoparticles
null
null
Dosage Forms

Partner with Callan Pharma

Callan Pharma provides its partners rapid, comprehensive and cost-effective solutions for their difficult formulation development projects.

Let's Talk